...
首页> 外文期刊>Journal of Medicinal Chemistry >Nonpeptide urotensin-II receptor antagonists: A new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits
【24h】

Nonpeptide urotensin-II receptor antagonists: A new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits

机译:非肽尿紧张素II受体拮抗剂:一种基于哌嗪子-邻苯二甲酰亚胺和哌嗪子-异吲哚满酮亚基的新配体类

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We have discovered two related chemical series of nonpeptide urotensin-II (U-II) receptor antagonists based on piperazino-phthalimide (5 and 6) and piperazino-isoindolinone (7) scaffolds. These structure types are distinctive from those of U-II receptor antagonist series reported in the literature. Antagonist 7a exhibited single-digit nanomolar potency in rat and human cell-based functional assays, as well as strong binding to the human U-II receptor. In advanced pharmacological testing, 7a blocked the effects of U-II in vitro in a rat aortic ring assay and in vivo in a rat ear-flushmodel. Adiscussion of U-II receptor antagonist pharmacophores is presented, and a specifically defined model is suggested from tricycle 13, which has a high degree of conformational constraint.
机译:我们发现了两个相关的化学系列的基于哌嗪子-邻苯二甲酰亚胺(5和6)和哌嗪子-异吲哚满酮(7)支架的非肽尿紧张素II(U-II)受体拮抗剂。这些结构类型不同于文献中报道的U-II受体拮抗剂系列。拮抗剂7a在基于大鼠和人类细胞的功能测定中显示出一位数的纳摩尔浓度,并且与人类U-II受体的结合力强。在高级药理学测试中,7a在大鼠主动脉环测定中体外和在大鼠耳冲洗模型中体内均阻断了U-II的作用。讨论了U-II受体拮抗剂药效团,并从三轮车13中提出了一个明确定义的模型,该模型具有高度的构象约束。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号